Diabetes Dialog applications are OPEN ! Largest hands on diabetes technology workshop for Endocrinology Fellows. October 24-27, 2024 All expenses will be covered for accepted fellows. Hurry up! Deadline July 15 to apply #endotwitter diabetesdialog.org

Our fellows at the ENDO2024 in Boston, MA showing off their poster presentations. Congratulations and we are very proud of them! They even bumped into our alumni fellow Abu. #stanfordendo #ENDO2024 Abubakr Hassabo Mohamed Jairo Noreña MD. Angela Rao, MD

This one is special. Grateful to Endocrine Society Journals #JCEM for the opportunity to work with Yasaman Motlaghzadeh to write about optimizing #BoneHealth in patients with #BreastCancer. Dedicated to my patients and fellow survivors 🎀 academic.oup.com/jcem/advance-a…

With the Stanford Endocrinology family after an amazing talk by my co-fellow Susan Seav! She presented her work on implementing EHR-integrated CGM protocol for insulin dosing, with the great mentoring of Mike Hughes. Proud to be part of such a dedicated team! #ADA2024

Wonderful oral presentation at #ADA2024 by ⁦Stanford Endocrinology ⁦Stanford Department of Medicine⁩ fellow Susan Seav discussing how we’ve implemented support for inpatient use of CGM at ⁦Stanford Health Care with accuracy and satisfaction data⁩!! 👏👏👏

Rayhan Lal, Endocrinologist and Assist Prof at ⁦Stanford Endocrinology⁩ discussing the false dichotomy of choosing innovation vs access with his wonderfully compassionate and frank style at #ADA2024 #ADASciSessions

Special thanks to Dr. Sellmeyer for her pivotal guidance in shaping my career path and connecting me with leading experts in the field, including Dr. Bilezikian. Here is our latest collaboration. Hypercalcemia Associated with Pregnancy and Lactation sciencedirect.com/science/articl…

Celebrating our graduating Stanford Endocrinology fellows! 🎓 Dr. Susan Seav will join the faculty as Clinical Assistant Professor, and Dr. Leor Needleman will continue his innovative research on the genetics of pheochromocytomas and paraganglionomas. Congratulations! 🥳🎉

Excited to share that I'll be joining Stanford Center for Digital Health as a #DigitalHealth Scholar🎉🥳 Looking forward to collaborating with Eleni Linos and the entire team, and to sharing how we can harness technology to enhance digital health and improve health outcomes 🌍👩🏻‍💻

New in Press at #EndocrinePractice Understanding the pharmacokinetics and glucodynamics of once weekly basal #insulins to inform dosing principles: an introduction to clinicians by Jose Buse and colleagues from Univ. Graz and Lilly #diabetes @Els_ENDO endocrinepractice.org/article/S1530-…

Do you have type 1 diabetes? Did you engage in regular exercise during pregnancy and are over 17 years of age? If yes… we need your help! FRENCH: redcap.ualberta.ca/surveys/?s=WJX… ENGLISH: redcap.ualberta.ca/surveys/?s=HLW… @BetterType1 @JDRF_Canada Banting & Best Diabetes Centre Joslin Diabetes Center Connected in Motion

Advancing use of CGM to guide #insulin dosing in hospital #diabetes Diabetes Care, a research journal of the ADA 🌟 Stanford Medicine diabetesjournals.org/care/article-a…

📢Excited to share our recent experience supporting patients to use their #CGM during hospital stays! 🚑 Amazing group on this paper! Check out how we're advancing #DiabetesCare at Stanford Endocrinology Stanford Health Care Stanford Department of Medicine. doi.org/10.2337/dc24-0…

We might have some strong feelings about #AID #T1D and #IOB. But at least we got them down on a #pdf. Take a look and share your thoughts. Thanks Dana M. Lewis | #OpenAPS 🤖 Lauren Turner Arsilan Rayhan and team captain Dessi Zaharieva journals.sagepub.com/doi/10.1177/19…

New research shows CGM use in hospitals benefits both patients and nurses. Could this be the future of diabetes care? Learn more: l8r.it/PA6Y #DiabetesCare #CGM

Transforming #diabetes care in #hospitals: implementation of personal #CGM use for #inpatient insulin dosing results in reliable CGM and positive patient & nurse experiences. #PatientCare ADA Professional Publications Read Here➡️ diabetesjournals.org/care/lookup/do…

Fascinating, humbling graph to study

We’re excited to share that the Omnipod® 5 Automated Insulin Delivery System is now indicated for adults with type 2 diabetes, ages 18+, making it the first and only AID system that is FDA-cleared for both type 1 & type 2 diabetes management. Learn more at omnipod.com/what-is-omnipo…

As part of our efforts to support broader access to innovative technology in diabetes management, we expanded the indications of the Insulet SmartAdjust technology, an interoperable automated glycemic controller previously indicated to manage type 1 diabetes in individuals two

Some interesting responses to a relatively straightforward survey: We asked people whether they used their #DiabetesDevices in the #hospital—and if so, how it went... #DiabetesTech #DiabetesCare #PatientExperience #CGM #InsulinPump doi.org/10.1111/dom.16…